Home / Mirtazapine / Japan
JP ATC N06AX11 · updated 2 Nov 2026
Mirtazapine shortage in Japan
Is there a Mirtazapine shortage in Japan?
Yes. As of 2 Nov 2026, 5 Mirtazapine products are reported short in Japan, the first since 7 Feb 2024. No return date has been given. Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Ireland, Austria, Belgium, Sweden, New Zealand, Australia. All countries.
Affected products in Japan
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | ミルタザピンOD錠30mg「アメル」 | Kyowa Pharmaceutical | 7 Feb 2024 | not given | Manufacturing problem |
| JP | ミルタザピン錠15mg「TCK」 limited | Tatsumi Kagaku | 19 Aug 2025 | not given | Manufacturing problem |
| JP | ミルタザピン錠15mg「杏林」 limited | キョーリンリメディオ | 9 Oct 2026 | not given | Active ingredient shortage Raw material (active ingredient) supply problem |
| JP | ミルタザピン錠30mg「TCK」 | Tatsumi Kagaku | 15 Oct 2026 | not given | Other |
| JP | ミルタザピンOD錠30mg「トーワ」 limited | Towa (Pensa) | 22 Oct 2026 | not given | Manufacturing problem |
Source
MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.